BioHarvest Sciences Inc. Common Stock Price & Performance (BHST)

BioHarvest Sciences' stock price climbed 3.88% on March 20, 2025, marking its fifth consecutive day of gains. The stock has increased by 23.03% over the past two weeks, driven by strong trading volume and technical buy signals. Analysts predict continued upward movement, with resistance expected around $7.23.12

BioHarvest Sciences has been rated as a "Strong Buy" by analysts, with a 12-month price target of $13.00, representing a 109.34% upside from its current price. The company’s innovative botanical synthesis technology and recent uplisting to Nasdaq are driving investor confidence.34

BioHarvest Sciences recently launched its VINIA SuperFood Functional Tea, targeting the $3.3 billion North American functional tea market. The product, infused with Piceid Resveratrol, highlights the company’s focus on health and wellness and its potential to diversify revenue streams.34